Adia Med, Inc. (ADIA) Form 8-K — Oct 19, 2026
On October 13, 2026, Adia Med, Inc. agreed to sell seven membership units (a 7% interest) in its subsidiary Adia Labs LLC to its own CEO, Larry A. Powalisz, for $350,000 in cash, or $50,000 per unit. The agreement gives the purchased units 7% of the voting power of the LLC and requires the operating agreement to be amended at closing to reflect the interest.
Key figures
- Deal Value Usd
- 350000
- Units sold
- 7
- Purchase price per unit
- 50000
- Membership interest percent
- 7%
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.